CANADIAN RESEARCH SUPPLIER • THIRD-PARTY TESTING
← Back to ShopView Cart
In Stock
FXLABS
RETATRUTIDE
In Stock
RETATRUTIDE
10 mg
$75.00
8 units available
Quantity
1
Latest Lab Status
No laboratory record published yet.
Product Information
Documentation
An investigational triple agonist acting on GLP-1, GIP, and glucagon receptors simultaneously — the added glucagon-receptor activity is thought to contribute an energy-expenditure effect on top of the appetite and glucose effects shared with the other two pathways. Still moving through clinical trials as of 2026, so the published evidence base is earlier-stage than semaglutide or tirzepatide.
Batch Documentation
Laboratory Results
No laboratory records available for this product.
Product Information Notice
Product information is provided for catalogue documentation and research-reference purposes.